Document 0294 DOCN M94A0294 TI Sodium benzylideneascorbate induces apoptosis in HIV-replicating U1 cells. DT 9412 AU Aoki K; Nakashima H; Hattori T; Shiokawa D; Ni-imi E; Tanimoto Y; Maruta H; Uchiumi F; Kochi M; Yamamoto N; et al; Department of Biochemistry, Faculty of Pharmaceutical Sciences,; Science University of Tokyo, Japan. SO FEBS Lett. 1994 Aug 29;351(1):105-8. Unique Identifier : AIDSLINE MED/94357260 AB U1 cells, a subclone of U937 cells chronically infected with human immunodeficiency virus type 1 (HIV-1), produced HIV-1 only in the presence of inducers such as 12-O-tetradecanoxylphorbol 13-acetate (TPA) or tumor necrosis factor (TNF)-alpha. The expression of HIV-antigen on U1 cells induced by TPA or TNF-alpha was found to be prevented by sodium 5,6-benzylidene-L-ascorbate (SBA) in a concentration-dependent manner. Treatment of U1 cells with SBA in the presence of inducers resulted in cell death with cell shrinkage, chromatin condensation and DNA fragmentation into nucleosomal oligomers, characteristics of apoptosis. In contrast, SBA had scarcely any apoptotic effect on U1 cells in the absence of inducers. SBA did not also induce apoptosis in parental U937 cells in the presence or absence of inducers. These results suggest that HIV-replicating U1 cells selectively undergo apoptosis on treatment with SBA. DE Antiviral Agents/*PHARMACOLOGY Apoptosis/*DRUG EFFECTS Ascorbic Acid/*ANALOGS & DERIVATIVES/PHARMACOLOGY Benzylidene Compounds/*PHARMACOLOGY Human HIV Antigens/ANALYSIS HIV-1/*DRUG EFFECTS Molecular Structure Support, Non-U.S. Gov't Tetradecanoylphorbol Acetate/PHARMACOLOGY Tumor Cells, Cultured Tumor Necrosis Factor/PHARMACOLOGY Virus Replication/DRUG EFFECTS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).